Board Of Directors


Prince Jeyabal, PhD


Dr. Prince Jeyabal is a research investigator from the University of Texas MD Anderson Cancer Center in Houston. He has had a stellar academic career with an unwavering commitment to basic investigation. His accomplishments in translational research laid him a strong foundation in innovative molecular cell signaling techniques and he has made great strides in this field. He has also addressed important issues in cardiac inflammation and repair. Furthermore, he has conducted research on the mechanistic role of microRNAs as a potential biomarker and their therapeutic implication in cardiomyopathy. He obtained his Biochemistry PhD from the University of Madras in India. He has authored and co-authored several peer-reviewed scientific publications, editorials, and book chapters.

Dr. Prince Jeyabal’s insight in molecular cell signaling techniques is an additional strength for our Lyme and tick-borne diseases research collaboration with several top universities. In addition to offering his insights in molecular biology, he is also serving as a core project coordinator.

Beverley headshot .jpg

Beverley F. Murphy, MHS


Beverley Murphy has a Master of Health Science from the Johns Hopkins School of Public Health. In the late 80's, she worked on a Women and AIDS health education and prevention project addressing the AIDS epidemic in women. Beverley attended the doctoral program at Columbia University in sociomedical sciences for two years where she held a prestigious graduate research assistant position. She co-authored a study on how physician health prevention behaviors impact patients.
She left Columbia as an "all but dissertation" PhD to pursue a business career but remained passionate about health sciences. She ran a successful four location yoga business in New York City, named Be Yoga, that she subsequently sold to Yoga Works in Los Angeles. After that, she joined MINDBODY INC., the largest health and wellness software company in the world. Beverley created and directed a user conference called MINDBODY University, teaching MINDBODY clients business fundamentals and how to use the software. This conference was held internationally and was attended by over 1000 clients each year. She also created and directed a client consulting program for MINDBODY. 

At the peak of her career, Beverley's life was derailed by a mysterious illness that no one could diagnose. For the past seven years, she has been treating what was eventually diagnosed as chronic Lyme. During this time, she has become passionate about helping those with Lyme and other tick-borne diseases. Her experience inspired her to join BioNeoMed where she hopes to play an integral part in curing tick-borne diseases.


Christopher Tiller


 An IT Professional, he is married to Pamila Samuel with two sons. 


Using his vacation days, he has travelled to Third world countries like Rwanda, Liberia in war torn Africa helping post-war disadvantaged children with their educational needs and setting up computer learning labs with local leaders.


He is our new treasurer and is helping our foundation, keeping the foundation as a good standing one, answering queries from the IRS & the state government. 

Dr Irudayam.jpg

Maria Johnson Irudayam, PhD

Board of Directors

Dr. Maria Johnson Irudayam is a research scientist in molecular biology with a multidisciplinary background. His past and present areas of research and expertise include macromolecular interactions, biochemistry and biochemical analysis, experimental hematology, basics of immunology, cancer genetics, cell signaling pathways, molecular genetics, mouse genetics, and neurobiology. Dr. Irudayam’s contributions have been published in esteemed journals such as Molecular Therapy, Diabetes, and PLOS Genetics. He obtained his education at premier institutions and universities in southern India. He received his Bachelor of Science at The American College, Madurai, Master of Science at St. Joseph’s College, Trichy, and PhD in the Department of Genetics at the University of Madras. He has given scientific talks and seminars, been a reviewer for peer-reviewed international journals, published research articles, contributed to book chapters. Currently, Dr. Irudayam has been working at the University of Tennessee on the bioenergetics of activin genes-deficient mouse embryonic fibroblasts in order to determine the role activin genes play in adiposity and metabolism. 

Dr. Maria Johnson Irudayam’s understanding in molecular biology is a added strength for our research team. He is also a blog writer on Lyme and tick-borne diseases.

RJM headshot 8-2018.jpg

Robert J Murphy

Board of Directors

Robert Murphy is an investor and entrepreneur involved in Software as a Service (SaaS) and healthcare-related businesses. Bob graduated from Boston University with a Bachelor of Science in Communications. After obtaining his bachelor’s, he began a career in commercial real estate in New York City and founded the first commercial real estate database listing company. He co-founded Be Yoga with his wife, Beverley, and sold the company to Yoga Works in 2004.

He was the co-founder and COO/CMO of MINDBODY, Inc. from 2005 to 2016. MINDBODY went public in 2015 and was purchased in 2019 by Vista Private Equities. Bob helped grow the company to over $150 million in revenue by 2016 and to over 60,000 customers worldwide. At MINDBODY, his duties included sales, marketing, and customer service. He continues to invest in and advise SaaS companies in the health and wellness industries. 

Bob became interested in Lyme disease research when his wife became ill with a mysterious illness that no one was able to diagnose. He has seen firsthand how the inadequacies of testing, research funding, and of the treatment of Lyme disease negatively affects patients and families. He is passionate about helping others with Lyme and bringing this epidemic to an end.

Dr. John Chan.jpg

Dr. John Chan, PhD

Board of Director

Dr. John Chan is the CEO of the Apelin Project, a company that aims to address critically unmet needs in healthcare. Prior to founding the Apelin Project, he was the founder and CEO of Aspira Scientific, which commercializes cutting-edge life science and chemistry technologies. Previously, he was the global marketing manager of the chemistry franchise for Sigma-Aldrich and achieved record-performance innovations . Dr. Chan spent 15 years in technology and commercial development. During this time, he worked on category-defining technologies including two projects  that won Nobel prizes . He obtained his Bachelor of Science in Chemistry and Economics from Duke University, graduating with distinction, summa cum laude. He received his PhD in Chemistry from Stanford University. His professional and personal passion is to create a healthier and sustainable future .

On a personal level, he has met with patients who have Lyme disease. He understands how terrible the disease is and lends full support to the foundation seeking to bring greater impact for Lyme patients and families.